Fed. Circ. Sides With Sanofi In Patent Spat With Novo
A federal appeals court has affirmed a district court's denial of Novo Nordisk A/S's request for a preliminary injunction in the drugmaker's yearlong patent feud with Sanofi-Aventis over a top-selling insulin...To view the full article, register now.
Already a subscriber? Click here to view full article